Glucose biosensor based on open-source wireless microfluidic potentiostat
Ó Conghaile, Peter
Rusling, James F.
MetadataShow full item record
This item's downloads: 43 (view details)
Cited 13 times in Scopus (view citations)
Mercer, Conan, Bennett, Richard, Conghaile, Peter Ó, Rusling, James F., & Leech, Dónal. (2019). Glucose biosensor based on open-source wireless microfluidic potentiostat. Sensors and Actuators B: Chemical, 290, 616-624. doi: https://doi.org/10.1016/j.snb.2019.02.031
Wireless potentiostats capable of cyclic voltammetry and amperometry that connect to the Internet are emerging as key attributes of future point-of-care devices. This work presents an "integrated microfluidic electrochemical detector" (iMED) three-electrode multi-potentiostat designed around operational amplifiers connected to a powerful WiFi-based microcontroller as a promising alternative to more expensive and complex strategies reported in the literature. The iMED is integrated with a microfluidic system developed to be controlled by the same microcontroller. The iMED is programmed wirelessly over a standard WiFi network and all electrochemical data is uploaded to an open-source cloud-based server. A wired desktop computer is not necessary for operation or program uploading. This method of integrated microfluidic automation is simple, uses common and inexpensive materials, and is compatible with commercial sample injectors. An integrated biosensor platform contains four screen-printed carbon arrays inside 4 separate microfluidic detection chambers with Pt counter and pseudo Ag/AgCl reference electrodes in situ. The iMED is benchmarked with K-3[Fe(CN)(6)] against a commercial potentiostat and then as a glucose biosensor using glucose-oxidising films of [Os(2,2'-bipyridine)(2)(polyvinylimidazole)(10)Cl] prepared on screen-printed electrodes with multi walled carbon nanotubes, poly(ethylene glycol) diglycidyl ether and flavin adenine dinucleotide-dependent glucose dehydrogenase. Potential application of this cost-effective wireless potentiostat approach to modern bioelectronics and point-of-care diagnosis is demonstrated by production of glucose oxidation currents, under pseudo-physiological conditions, using mediating films with lower redox potentials.